Article
Transformative Potential of Induced Pluripotent Stem Cells in Congenital Heart Disease Research and Treatment
23 May 2025
Abstract excerpt
Congenital heart disease (CHD), the most common congenital anomaly, remains a significant lifelong burden despite advancements in medical and surgical interventions. Induced pluripotent stem cells (iPSCs) have emerged as a groundbreaking platform in CHD research, offering patient-specific models to investigate the genetic, epigenetic, and molecular mechanisms driving the disease. Utilizing technologies such as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
